In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.Gregory P. Dubé, W L Kurtz, Joseph A. Jakubowski et al.|Journal of Pharmacology and Experimental Therapeutics|1995Cited by 3
ChemInform Abstract: Thromboxane A2 Receptor Antagonists. Synthesis and Activities of Phenylsulfonamido Derivatives.Dale E. Mais, Joseph A. Jakubowski, F. MOHAMADI et al.|ChemInform|1992Cited by 0